Can Oral Gildeuretinol Slow Advanced Macular Degeneration?

• by Andrea Surnit

• July 20, 2026

Stuart Therapeutics Spotlights Topical RP Program

At OIS Retina, Eric Schlumpf discussed the company’s collagen mimetic peptide platform for retinitis pigmentosa, now in preclinical development.

• by Eric Schlumpf

• July 15, 2026

• 2 min

Nonexudative Macular Neovascularization in Age-Related Macular Degeneration

• by Sridevi Thottarath, Sarega Gurudas, Syed Kubravi, Dimitrios Kazantzis, Ayse Merve Keskin, Sobha Sivaprasad, EYENEON Study Group, Benjamin Burton, Geeta Menon, Manju Chandran, Ian Pearce, Savita Madhusudhan, Anna Grabowska, Faruque Ghanchi, James Talks, Richard Gale, Martin McKibbin, Ajay Kotagiri, Niro Narendran, Afsar Jafree, Saad Younis, Claire Bailey, Priya Prakash, Christiana Dinah, Louise Downey, Andrew Lottery, Paritosh Shah, Romi Chhabra, Narendra Dhingra, Indra Dias, Mary Freeman, Daren Hanumunthadu

• May 1, 2026

Robust and reproducible population receptive field mapping in patients with retinal pathologies

• by Maximilian Pawloff, David Linhardt, Michael Woletz, Marlene Hollaus, Georgios Mylonas, Graham E. Holder, Stefan Sacu, Christian Windischberger, Markus Ritter

• June 4, 2026